Track the Senzime AB (publ.) share price and the full insider trade history of the company, a listed equity based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Senzime AB (publ.) has recorded 5 public disclosures. Market capitalisation: €581.7m. The latest transaction was filed on 9 December 2025 (Purchase). Among the most active insiders: Lars Axelsson. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
€104,477
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Senzime AB (publ.) Strong Buy (bullish), based on 1 analysts. Average price target: SEK 10.50.
28Σ signal
Buys €104,477n/a Sells
Fundamental score
Ranked 26,838 of 29,063 companies
19.2
score / 100
Value
9
Quality
29
FCF yld-22%
Earn yld-24%
EV/EBITDA·
ROE-35%
Gross mgn33%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
150,000 shares@ €0.37060.0079% mcap100.0% of flowAktieISINISIN SE0002478776FI:A003N503-1
5 of 5 declarations
Acerca de Senzime AB (publ.)
Senzime AB es una empresa sueca centrada en el desarrollo de soluciones de monitorización de pacientes para la atención sanitaria. Cotiza en el mercado XSTO.